Caitlin Raymond: Most “Difficult Patients” Aren’t Difficult at All
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared on LinkedIn:
”We talk about “difficult patients” all the time in healthcare — but I’m increasingly convinced we’re labeling the wrong thing.
Two encounters made this hard to ignore:
• A wife described as “the meanest person I’ve ever met.”
In reality, her husband was paralyzed after a medical error and lying in the ICU. She wasn’t hostile — she was terrified, grieving, and fighting for someone she loved in a system that had started keeping her at arm’s length.
• An incarcerated sickle cell patient labeled with “behavioral issues.”
When I sat down, made eye contact, and actually listened, he was thoughtful, honest, and warm. The “behavior” dissolved the moment his humanity was acknowledged.
Neither of these people were “difficult.” They were reacting in completely understandable ways to trauma, fear, power imbalance, and — frankly — how they were being treated.
This is attribution bias in action: assuming behavior comes from personality instead of context. Neuroscience tells us most behavior in high-stress situations is driven by the limbic system, not stable traits. When people are overwhelmed, afraid, or unheard, their frontal lobes go offline. What we call “difficult” is often just neurobiology.
The problem isn’t the patient.
The problem is our interpretation.
When we shift from a fixed mindset (“they’re just like that”) to a growth mindset (“their behavior makes sense in this situation”), our interactions change. Outcomes change. Trust changes.
Most “difficult patients” aren’t difficult at all. They’re people navigating difficult circumstances.
Full piece here.”

Stay updated with Hemostasis Today.
-
Mar 13, 2026, 22:57Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
-
Mar 13, 2026, 22:05Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
-
Mar 13, 2026, 21:29Timothy Glidewell: Genetic Signals of Platelet and Clotting Pathways in Cryptogenic Stroke
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”